Physicians’ Education Resource® to Present Six Satellite Symposia at Annual American Society of Hematology Meeting and Exposition

“We are once again grateful for the opportunity to present our satellite symposia during this year’s American Society of Hematology’s annual meeting,” said Phil Talamo, president of PER^®. “The six unique programs offered to attendees will feature an acute lymphoblastic leukemia (ALL) Medical Crossfire®, a cutting-edge program that discusses the latest therapeutic developments for patients with AML, GvHD, hemolytic anemia, MPNs, and a program that offers a mixed format of didactic lectures, panel discussions and interactive clinical case studies of hematologic disorders.”

The PER^® satellite symposia are as follows:

• ASH: Medical Crossfire®: How the Experts Treat Acute Lymphoblastic Leukemia: Case Discussions from Adolescent to Adult, which will be held from 1:30-4:30 p.m. at the Marriot Marquis San Diego Marina in the Grand Ballroom 8-9 (lobby level). The symposia will be chaired by Elias Jabbour, M.D., associate professor of medicine, department of leukemia, the University of Texas MD Anderson Cancer Center. During the luncheon symposium, distinguished faculty members will discuss key topics including, factors that may influence risk stratification and treatment decisions, methods to best integrate the latest therapies into acute lymphoblastic leukemia treatment paradigms, barriers to optimized integration of these novel agents, and best practices to assist you with the management of adverse events. To register, visit https://www.gotoper.com/conferences/ash18all/meetings/how-the-experts-treat-acute-lymphoblastic-leukemia-case-discussions-from-adolscent-to-adult/registration.
• ASH: Advancing Care for Patients with GvHD: Making Sense of Recent Approvals and Late-Stage Compounds, which will be held from 1:30-4:30 p.m. at the Manchester Grand Hyatt San Diego in the Grand Hall D (lobby level). Corey Cutler, M.D., MPH, FRCPC activity chair and associate professor of medicine, Harvard Medical School, and director of clinical research, stem cell transplantation, Dana-Farber Cancer Institute, will delve into the most recent clinical advances in novel diagnostic, therapeutic, and patient counseling strategies that will potentially impact management of patients with acute and chronic graft-versus-host disease. To register, visit https://www.gotoper.com/conferences/ash18gvhd/meetings/advancing-care-for-patients-with-gvhd-making-sense-of-recent-approvals-and-late-stage-compounds/registration.
• ASH: “D” Is for Diagnosis”: Solving the Mystery of Rare Hematologic Disorders, which will be held from 1:30-4:30 p.m. at the Marriot Marquis San Diego Marina in the Grand Ballroom 1-4 (lobby level). The symposia will be chaired by Pramod K. Mistry, M.D., Ph.D., FRCP, FAASLD, professor of medicine and pediatrics, department of internal medicine (digestive diseases), professor of cellular and molecular physiology, director of Yale Lysosomal Disease Center and Gaucher Disease Treatment Center, Yale University of Medicine. During the luncheon symposia, renowned experts in uncommon blood disorders will review the latest clinical data, share their best practices, review new and emerging strategies in the context of existing diagnostic and therapeutic algorithms. To register, visit https://www.gotoper.com/conferences/ash18diagnosis/meetings/solving-the-mystery-of-rare-hematologic-disorders/registration.
• ASH: Differentiating Diagnosis and Treatment to Fit the Patient With Hemolytic Anemia: A Case-Based Approach, which will be held from 1:30-4:30 p.m. at the Marriot Marquis San Diego Marina in the Grand Ballroom 10-13 (lobby level). The symposia will be chaired by Janet Kwiatkowski, M.D., MSCE, director of the Thalassemia Center, Children’s Hospital of Philadelphia, professor of pediatrics, Perelman School of Medicine, University of Pennsylvania. During the luncheon symposia, renowned clinical educators will highlight recent clinical advances in novel diagnostic, therapeutic, and patient counseling strategies to maximize treatment and management of your patients with hemolytic anemias. This includes efficacy considerations, as well as development of strategies to identify and mitigate predictable treatment-related adverse events in a timely fashion. To register, visit https://www.gotoper.com/conferences/ash18hemolytic/meetings/differentiating-diagnosis-and-treatment-to-fit-the-patient-with-hemolytic-anemia-a-case-based-approach/registration.
• ASH: Advancing Polycythemia Vera and Myelofibrosis: An Expert Tumor Board Discussion, which will be held from 1:30-4:30 p.m. at the Marriot Marquis San Diego Marina in the Grand Ballroom 5-6 (lobby level). The symposia will be chaired by Brady Lee Stein M.D., program chair and associate professor of medicine, Feinberg School of Medicine, Northwestern University. During the luncheon symposia, renowned international experts in myeloproliferative neoplasm (MPN) treatment and clinical research in an in-depth tumor board format, will assess the clinical impact of recent and emerging trial data on the development of treatment paradigms. A series of case presentations will be discussed, with clinical trial data tightly integrated to illuminate MPN treatment decisions related to frontline-and-beyond therapies, sequencing, switching, and patient and disease characteristics. Future directions in the field will also be addressed and considered with regard to how recent developments and highly anticipated trials may shape care in the near future. To register, visit https://www.gotoper.com/conferences/ash18tumor/meetings/advancing-polycythemia-vera-and-myelofibrosis-an-expert-tumor-board-.discussion/registration.
• ASH: New Therapies for Better Patient Outcomes in Acute Myeloid Leukemia: Integration of Recent Data Sets Into Clinical Practice, which will be held from 7:00-10:00 p.m. at the Manchester Grand Hyatt San Diego in the Grand Hall D (lobby level). Naval G. Daver, M.D, associate professor, department of leukemia, division of cancer medicine, the University of Texas MD Anderson Cancer Center, will present a cutting-edge program designed to help attendees apply with confidence the latest therapeutic developments for their patients with acute myeloid leukemia. To register, visit https://www.gotoper.com/conferences/ash18aml/meetings/new-therapies-to-better-patient-outcomes-in-acute-myeloid-leukemia-integration-of-recent-data-sets-into-clinical-practices/registration.

About Physicians’ Education Resource^® (PER^®)

Since 1995, PER^® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER^® initiated CME programming in the cardiovascular and endocrinology areas and continues to grow its therapeutic reach outside oncology. PER^® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading, distinguished experts who focus on the application of practice-changing advances. In 2018, PER^® will develop and implement 21 historic annual legacy conferences in the United States and Europe, along with many renowned online learning formats. PER^® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER^® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181121005415/en/